Screening & Diagnostics

Insights and analysis on screening and diagnostic technologies shaping modern healthcare. This category covers disease screening programs, diagnostic imaging, in vitro diagnostics, point of care testing, pathology solutions, and early detection tools used across hospitals, labs, and preventive care settings. Content focuses on market trends, technology innovation, regulatory developments, and global adoption patterns.

China gastric cancer screening market size forecast 2024 to 2033 showing growth from 11126 million to 16597 million US dollars

China Gastric Cancer Screening Market Forecast 2024–2033

Analysis India: The China Gastric Cancer Screening Market is one of the most significant and rapidly evolving segments within the global cancer diagnostics landscape. China has one of the highest incidences of gastric cancer globally, making screening programs a national healthcare priority. As a result, the country has developed structured and large-scale screening initiatives that […]

China Gastric Cancer Screening Market Forecast 2024–2033 Read More »

United States gastric cancer screening market size forecast 2024 to 2033 showing growth from 2371 million to 4547 million US dollars

United States Gastric Cancer Screening Market Size to Reach $4,547 Million by 2033

Analysis India: The United States Gastric Cancer Screening Market is witnessing steady transformation driven by rising awareness of early cancer detection, advancements in diagnostic technologies, and increasing healthcare investments. Gastric cancer, although less prevalent in the United States compared to Asian countries, remains a critical area of clinical focus due to late-stage diagnosis and associated

United States Gastric Cancer Screening Market Size to Reach $4,547 Million by 2033 Read More »

Global Gastric Cancer Screening Market trends growth AI diagnostics endoscopy and non invasive testing

Global Gastric Cancer Screening Market: 2026 Growth, Regional Insights, Technology Trends and Future Outlook

Analysis India: The global gastric cancer screening market is rapidly emerging as a critical segment within the broader oncology diagnostics industry, driven by the urgent need for early detection and improved survival outcomes. Gastric cancer continues to remain one of the leading causes of cancer-related mortality worldwide, particularly in high-risk regions such as East Asia,

Global Gastric Cancer Screening Market: 2026 Growth, Regional Insights, Technology Trends and Future Outlook Read More »

South East Asia Liquid Biopsy Cancer Screening Market Size Forecast 2024 to 2033 growth from 0.5 billion USD to 1.9 billion USD driven by rising cancer diagnostics demand

South East Asia Liquid Biopsy Cancer Screening Market Forecast 2033 Growth Trends and Strategic Insights

The South East Asia Liquid Biopsy Cancer Screening Market is gaining strong momentum as healthcare systems across the region move toward early cancer detection and precision diagnostics. In recent years, liquid biopsy has evolved from a niche research tool into a practical clinical solution, enabling non invasive cancer detection through blood based biomarkers. This transformation

South East Asia Liquid Biopsy Cancer Screening Market Forecast 2033 Growth Trends and Strategic Insights Read More »

Japan Liquid Biopsy Cancer Screening Market Size Forecast 2024 2033 Growth Trends Analysis

Japan Liquid Biopsy Cancer Screening Market Growth Outlook 2033: Key Trends, Forecast, and Strategic Insights

Introduction The Japan Liquid Biopsy Cancer Screening Market is emerging as a critical segment within the global oncology diagnostics landscape, driven by technological innovation, rising cancer prevalence, and Japan’s strong healthcare infrastructure. As healthcare systems transition toward non-invasive and early detection methods, liquid biopsy has become a transformative solution for cancer screening and monitoring. Japan,

Japan Liquid Biopsy Cancer Screening Market Growth Outlook 2033: Key Trends, Forecast, and Strategic Insights Read More »

×